Medicenna Therapeutics Corp. (MDNAF)

Medicenna Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	53	96	45	73	215	119
Market Cap Growth	305.00%	111.19%	-38.33%	-65.83%	80.82%	631.41%
Enterprise Value	32	80	19	55	189	114
Last Close Price	0.68	1.37	0.63	1.28	4.08	2.55
PB Ratio	7.40	24.95	2.08	4.40	7.09	4.66
P/TBV Ratio	7.42	25.23	2.08	4.42	7.10	4.67
Debt / Equity Ratio	0.01	-	-	-	0.00	0.00
Quick Ratio	9.90	1.30	4.95	8.33	9.93	20.80
Current Ratio	10.09	1.37	5.23	8.92	10.26	20.86
Return on Equity (ROE)	-149.09%	-146.88%	-39.94%	-76.56%	-46.54%	-42.70%
Return on Assets (ROA)	-42.09%	-42.00%	-34.02%	-42.75%	-27.10%	-23.87%
Return on Capital (ROIC)	-64.43%	-67.31%	-40.50%	-47.60%	-29.23%	-26.54%
Earnings Yield	-35.26%	-19.66%	-16.40%	-24.62%	-6.40%	-4.91%
FCF Yield	-21.47%	-12.55%	-20.65%	-25.72%	-5.66%	-3.21%
Buyback Yield / Dilution	-7.07%	-7.57%	-19.25%	-9.31%	-55.68%	-24.25%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.